5 Best Performing Biotech ETFs in 2024

Page 1 of 5

In this article, we discuss 5 best biotech ETFs to buy. If you want to read our discussion on the biotech industry, head directly to 10 Best Performing Biotech ETFs in 2024.

5. Putnam BioRevolution ETF (NYSE:SYNB)

5-Year Share Price Performance as of April 20: 15.67%

The Putnam BioRevolution ETF (NYSE:SYNB) is designed to pursue long-term capital growth by investing in a carefully curated portfolio of 30-50 stocks. As of April 18, the fund boasts net assets totaling $5.43 million, coupled with an expense ratio of 0.70%.

Among the top holdings of the Putnam BioRevolution ETF (NYSE:SYNB) is Thermo Fisher Scientific Inc. (NYSE:TMO). Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in providing life sciences solutions, analytical instruments, specialty diagnostics, laboratory products, and biopharma services. On February 1, RBC Capital analysts reaffirmed an Outperform rating and set a price target of $642 for Thermo Fisher Scientific Inc. (NYSE:TMO).

In the fourth quarter, a total of 111 hedge funds maintained long positions in Thermo Fisher Scientific Inc. (NYSE:TMO), collectively holding a stake valued at $10.3 billion.

Page 1 of 5